Protocol·One
Editorial reference, not medical advice. Lab values are one input into a clinical picture, not a diagnosis. Numbers outside the ranges shown here are not grounds for alarm without context - and numbers inside them are not a clean bill of health. Lab interpretation belongs with a clinician who knows your history.

Cardiovascular biomarkers · Blood panel · Updated May 2026

ApoB optimal range: why it beats LDL for cardiovascular risk

ApoB (apolipoprotein B) counts the actual number of artery-damaging lipoprotein particles in your blood. The standard lab reference range is under 130 mg/dL. The longevity-optimal target most cardiovascular-focused clinicians aim for is under 80 mg/dL. LDL cholesterol misses cases ApoB catches - which is why cardiovascular researchers increasingly treat it as the primary lipid risk marker. If your ApoB is elevated, that is the conversation to have with a clinician.

New here? Start with the foundations ->

The dad-test answer in two paragraphs

ApoB is a protein that sits on the outer shell of every atherogenic lipoprotein particle in your blood - LDL, VLDL, IDL, and Lp(a). There is exactly one ApoB molecule per particle. So when your lab reports ApoB, it is reporting the particle count directly. LDL cholesterol tells you how much cholesterol those particles are carrying. ApoB tells you how many particles are there in the first place. For cardiovascular risk, the particle count is what matters - a high number of small, lightweight LDL particles can produce a normal-looking LDL cholesterol number while your ApoB tells a different story.

The standard lab reference range is under 130 mg/dL for most adults. The longevity-optimal target - the number cardiovascular-focused physicians often set as a goal for their serious-about-prevention patients - is under 80 mg/dL. That tighter target is a functional-medicine goal, more aggressive than population reference ranges, and not yet universal medical consensus. It is based on evidence that cardiovascular risk appears to decrease continuously as ApoB falls, with no clear floor in the range most people occupy. Discuss your specific number with a clinician before making any decisions about treatment.

What ApoB actually measures

Every lipoprotein particle that can deposit cholesterol into arterial walls - LDL (low-density lipoprotein), VLDL (very-low-density lipoprotein), IDL (intermediate-density lipoprotein), and Lp(a) (lipoprotein-a) - carries exactly one copy of the ApoB protein on its surface. HDL, the "good" cholesterol particle, does not carry ApoB.

That one-to-one ratio is the key fact. Because each particle has precisely one ApoB, measuring ApoB gives you an accurate particle count for everything potentially atherogenic in your blood. You are not measuring how much cholesterol they carry; you are measuring how many particles there are. And in large cardiovascular outcome studies, particle count has consistently predicted events like heart attack and stroke better than cholesterol mass.

The mechanism is straightforward: atherogenesis (plaque buildup in arteries) requires a lipoprotein particle to enter the arterial wall. More particles crossing the wall means more opportunities for plaque formation. The cholesterol each particle carries matters less than how many particles are attempting to cross.

Why LDL cholesterol can mislead

LDL-C (LDL cholesterol) measures the total amount of cholesterol inside LDL particles. But two people can have the same LDL-C with very different particle counts. A person with large, buoyant LDL particles has fewer particles per milligram of cholesterol. A person with small, dense LDL particles has more particles carrying the same total cholesterol load. Their LDL-C numbers look identical. Their ApoB numbers do not.

This discordance - identical LDL-C but different ApoB - is more common than most people expect. Insulin resistance, metabolic syndrome, type 2 diabetes, and high triglycerides all tend to shift LDL particles toward the smaller, denser pattern. So the populations most at risk are also the populations most likely to be under-counted by LDL-C alone.

Non-HDL cholesterol (total cholesterol minus HDL) is a partial improvement over LDL-C because it captures the cholesterol in all atherogenic particles, not just LDL. But it still measures cargo, not count. ApoB is the most direct available measure.

Reference range vs longevity-optimal: both matter

Most labs report a standard reference range and a risk-stratified set of targets. Here is how they compare:

Category ApoB level (mg/dL) Notes
Standard lab reference (low risk) < 100 mg/dL Commonly used by labs for average-risk adults; some labs use <130
Borderline / intermediate risk 100 - 129 mg/dL Watch range; clinical judgment on whether to treat
Elevated (high risk) ≥ 130 mg/dL Most labs flag this range; treatment discussion typically warranted
Longevity-optimal target < 80 mg/dL Functional-medicine / prevention-focused goal; not universal consensus - see caveat below
High-risk or existing CVD target < 60 mg/dL Used by some cardiologists in secondary prevention; aggressive, requires medical supervision

The caveat, stated plainly: The longevity-optimal target of under 80 mg/dL reflects the view - supported by Mendelian randomization studies and mechanistic reasoning - that lower ApoB reduces cardiovascular risk, and that the population reference range is not the same as an optimal range. That said, these targets are more aggressive than guidelines from major cardiology societies, which currently focus on LDL-C rather than ApoB as a primary treatment target. Whether you should aim for under 80 mg/dL depends on your full risk profile, your Lp(a), your family history, your other metabolic markers, and what interventions you are willing to take. That is a conversation for a clinician, not a number to chase in isolation. Both ranges are shown here because both are real and both matter - but they answer different questions.

ApoB vs LDL vs non-HDL: which to track

Marker What it measures Included in standard lipid panel Catches discordance
LDL-C Cholesterol mass inside LDL particles Yes No
Non-HDL-C Cholesterol mass in all atherogenic particles Calculated from standard panel Partial
ApoB Count of all atherogenic lipoprotein particles No - must order separately Yes
LDL-P (NMR) LDL particle number via NMR spectroscopy No - specialized test Yes (LDL particles only)

The practical recommendation: if your standard lipid panel looks borderline or you have risk factors (metabolic syndrome, family history of early heart disease, high triglycerides), add ApoB to your next panel. The test is not expensive and the information gap it closes is real.

What to do if your ApoB is elevated

An elevated ApoB is not a diagnosis and it is not an emergency. It is information. Here is what that information calls for:

Step 1: Understand the full picture before treating

ApoB elevated in isolation means something different from ApoB elevated alongside high Lp(a), insulin resistance, or a family history of early-onset heart disease. Before deciding on a treatment path, a complete cardiovascular risk assessment should include ApoB, Lp(a), hs-CRP (a marker of inflammation), fasting glucose and insulin, and your 10-year cardiovascular risk score. The cardiovascular blood panel covers these markers in full and explains what each one means.

Step 2: Lifestyle interventions for borderline numbers

For people in the borderline range (100-129 mg/dL), lifestyle changes can meaningfully lower ApoB. The most evidence-backed approaches:

  • Reduce saturated fat - swapping saturated fat for unsaturated fat (olive oil, nuts, avocado, fatty fish) lowers LDL-C and ApoB
  • Increase soluble fiber - oats, legumes, and psyllium husk bind bile acids in the gut and reduce LDL synthesis in the liver
  • Lose visceral fat if present - insulin resistance drives small dense LDL particle production; reducing it through weight loss and aerobic exercise directly lowers ApoB
  • Reduce refined carbohydrates and alcohol - both elevate VLDL, which contributes to ApoB
  • Consistent aerobic exercise - 150+ minutes per week of moderate intensity has a modest but real effect on the lipid profile

Step 3: When medication is the conversation

For people with ApoB consistently above 130 mg/dL, existing cardiovascular disease, familial hypercholesterolemia, or high calculated 10-year risk, lifestyle alone is usually not enough. Statins are the first-line medication with the strongest evidence base for reducing cardiovascular events. Ezetimibe is commonly added. PCSK9 inhibitors are injectable biologics that can cut ApoB dramatically for high-risk patients who need to get very low. This is the conversation to have with a cardiologist or an internist who specializes in cardiovascular prevention - not a decision to make based on a blog post.

Services like Ageless run a cardiovascular panel at intake and can connect you with a clinician to interpret results in context of a broader longevity protocol. See the longevity Rx matrix for that option.

What about peptides and supplements?

There is no peptide with meaningful evidence for lowering ApoB or LDL particles. Berberine has some modest LDL-lowering data and is sometimes used in functional medicine, but its effect size is substantially smaller than statins and it should not substitute for medication in people with elevated risk. Red yeast rice contains monacolin K (a natural statin) and can lower LDL-C, but the dose is variable, quality control is poor, and if you are taking it for statin-equivalent benefit you should probably be taking a proper statin with proper oversight instead. GLP-1 agonists (semaglutide, tirzepatide) improve the lipid profile as a secondary effect of weight loss and metabolic improvement - relevant for people using them for those primary purposes, not a cardiovascular drug in the primary-prevention sense. The honest answer: ApoB elevation is one of the few longevity problems where the prescription-medication path has overwhelmingly stronger evidence than any supplement, and trying to handle it with supplements when medication is warranted is the higher-risk choice.

Frequently asked questions

What is ApoB?

ApoB (apolipoprotein B) is a protein that sits on the surface of every atherogenic lipoprotein particle - LDL, VLDL, IDL, and Lp(a). There is exactly one ApoB molecule per particle, so an ApoB measurement is a direct count of the number of potentially artery-damaging particles in your blood. That is why it is more informative than LDL cholesterol, which measures the amount of cholesterol carried by those particles - not the number of particles doing the carrying.

What is the optimal ApoB number?

Standard lab reference ranges typically flag ApoB above 130 mg/dL as elevated (some labs use 100 mg/dL as the upper boundary for average-risk adults). The longevity-optimal target commonly cited by cardiovascular-focused physicians and researchers is under 80 mg/dL - and for people with existing cardiovascular disease or very high risk, some clinicians target under 60 mg/dL. These tighter targets are functional-medicine goals, more aggressive than population reference ranges, and not universal medical consensus. They reflect the principle that lower ApoB appears to confer lower cardiovascular risk continuously, with no obvious floor in observational data. Discuss your specific number and target with a clinician who knows your full picture.

ApoB vs LDL vs non-HDL cholesterol - which should I track?

ApoB is the most direct measure of atherogenic particle burden. LDL cholesterol can be misleading: a person with small dense LDL particles can have a normal LDL-C but an elevated ApoB - more particles present than the cholesterol number suggests. Non-HDL cholesterol is a step better than LDL-C because it captures cholesterol in all atherogenic lipoproteins, but it still measures cargo, not particle count. For people who want the most precise cardiovascular risk assessment, ApoB is the better test. If your LDL-C and non-HDL are both solidly low and you have no other risk factors, the additional cost of ApoB is debatable. If your LDL-C is borderline or you have metabolic syndrome, ApoB often tells the real story.

How do I lower ApoB?

The most effective interventions are the same ones that lower LDL-C: statins (first-line prescription medications with the strongest evidence for cardiovascular outcomes), PCSK9 inhibitors (injectable biologics for high-risk patients), ezetimibe (a non-statin option often added to statins), and dietary changes - reducing saturated fat, increasing soluble fiber, reducing refined carbohydrates. Lifestyle changes alone - aerobic exercise, weight loss if overweight - can meaningfully lower ApoB for people in the borderline range. For people with familial hypercholesterolemia or existing cardiovascular disease, medication is almost always necessary. Work with a clinician to set a target and a plan.

Is ApoB genetic?

Partly, yes. A significant share of ApoB variation is heritable. Familial hypercholesterolemia (FH) is the most common inherited condition causing very high ApoB and LDL-C, affecting roughly 1 in 200 to 1 in 250 people - many undiagnosed. If you have a first-degree relative who had a heart attack before age 55 (men) or 65 (women), or if your ApoB stays elevated despite reasonable diet and lifestyle, genetic testing for FH is worth discussing with your doctor. Having elevated ApoB does not automatically mean it is genetic - diet, insulin resistance, hypothyroidism, and other modifiable factors contribute - but the genetic piece matters because it changes how aggressively you need to treat.

What blood test measures ApoB?

ApoB is measured by a standard blood draw, but it is not included in a routine cholesterol panel - you or your doctor need to order it specifically. Some comprehensive metabolic panels and advanced cardiovascular panels include it automatically. Direct-to-consumer lab services can run it without a doctor's order in most US states. If you want ApoB interpreted in the context of a full cardiovascular risk picture - including Lp(a), hs-CRP, and other markers - the cardiovascular blood panel is the right starting point. For at-home options, see the best at-home blood tests page.

How we make money on this page

There are no lab-testing affiliate partners on this page. We do not earn a commission on ApoB tests or on any direct-to-consumer lab service. If you go through a longevity telehealth service via the link to the longevity Rx matrix, we may earn a commission at no cost to you. Full disclosure.

Where to go next

Last reviewed - 2026-05-31